OneSource Specialty Pharma Limited (NSE:ONESOURCE)

Market Cap	251.14B
Revenue (ttm)	14.45B
Net Income (ttm)	-179.71M
Shares Out	114.47M
EPS (ttm)	-1.63
PE Ratio	n/a
Forward PE	67.20
Dividend	n/a
Ex-Dividend Date	n/a

Volume	191,033
Average Volume	363,893
Open	1,967.00
Previous Close	1,947.50
Day's Range	1,911.80 - 2,000.00
52-Week Range	1,209.95 - 2,248.00
Beta	n/a
RSI	55.54
Earnings Date	Jul 29, 2025

About NSE:ONESOURCE

OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India and internationally. The company provides end-to-end CDMO services across various phases of preclinical and clinical development and commercial supply of biologics. It also offers drug-devices, including prefilled syringes, dial and push variable and fixed dose pen injectors, pull push fixed dose pens, and autoinjectors; sterile injectables; s...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 525
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ONESOURCE

Financial Performance

In 2024, NSE:ONESOURCE's revenue was 14.45 billion, an increase of 740.43% compared to the previous year's 1.72 billion. Losses were -179.71 million, -95.41% less than in 2023.